ADS VeriChip Marketing Campaign Gets Under FDA’s Skin – Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
Applied Digital Solutions' VeriChip subcutaneous, microchip-based information repository could pose minor health risks and likely would be deemed Class II with special controls under Center for Devices & Radiological Health oversight, device center reps suggest
You may also be interested in...
VeriChip Successors To Be 510(k)-Exempt, Special Controls Guidance Issued
Implantable radiofrequency transponder systems for patient identification and health information will be premarket-exempt but subject to special controls, FDA explains in a final rule that takes effect Jan. 10
VeriChip Successors To Be 510(k)-Exempt, Special Controls Guidance Issued
Implantable radiofrequency transponder systems for patient identification and health information will be premarket-exempt but subject to special controls, FDA explains in a final rule that takes effect Jan. 10
Digital ID Company Chips Away At Ortho Firms, Chronic Disease Markets
Applied Digital Solutions will attempt to persuade orthopedic joint replacement manufacturers of the clinical utility of its VeriChip implantable radiofrequency microchip